We began by querying the GTEx and TCGA databases, revealing pronounced ASF1B upregulation in all cancers other than Acute Myeloid Leukemia (LAML) (Figure 1A), as further confirmed using Oncomine data (Figure 1B). This evidence concerns the gene ASF1B and cancer.